These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16800972)

  • 41. Interval breast cancer: a more aggressive subset of breast neoplasias.
    DeGroote R; Rush BF; Milazzo J; Warden MJ; Rocko JM
    Surgery; 1983 Oct; 94(4):543-7. PubMed ID: 6623354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature.
    Montgomery DA; Krupa K; Cooke TG
    Br J Cancer; 2007 Dec; 97(12):1632-41. PubMed ID: 18000508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insights into breast cancer screening of younger women. Evidence from the 14-year follow-up of the Breast Cancer Detection Demonstration Project.
    Smart CR; Hartmann WH; Beahrs OH; Garfinkel L
    Cancer; 1993 Aug; 72(4 Suppl):1449-56. PubMed ID: 8339237
    [No Abstract]   [Full Text] [Related]  

  • 44. Improvement in outcomes of breast cancer patient treatment in Poland in the 21st century.
    Kołacińska A; Herman K; Morawiec J; Paszek S; Zawlik I; Śliwczyński A
    Breast J; 2019 May; 25(3):474-478. PubMed ID: 30982222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Survival of breast cancer patients in the Republic of Buryatia].
    Pisareva LF; Odintsova IN; Ananina OA; Zhuikova LD; Perinov DA; Panferova EV; Cherdyntseva NV; Choinzonov EL
    Vopr Onkol; 2016; 62(5):606-610. PubMed ID: 30695584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Survival after combined therapy of breast cancer].
    Novotná L; Bergsteinová V
    Rozhl Chir; 1981 Jun; 60(6):389-94. PubMed ID: 7268585
    [No Abstract]   [Full Text] [Related]  

  • 47. [What are the consequences of a delay in decision making after breast cancer detection?].
    Tristant H
    Presse Med; 1999 Sep; 28(27):1469-70. PubMed ID: 10520318
    [No Abstract]   [Full Text] [Related]  

  • 48. First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer.
    Capasso A; Bagby SM; Dailey KL; Currimjee N; Yacob BW; Ionkina A; Frank JG; Kim DJ; George C; Lee YB; Benaim E; Gittleman B; Hartman SJ; Tan AC; Kim J; Pitts TM; Eckhardt SG; Tentler JJ; Diamond JR
    Mol Cancer Ther; 2019 Nov; 18(11):1916-1925. PubMed ID: 31488700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between circulating and tissue microRNAs in a murine model of breast cancer.
    Waters PS; McDermott AM; Wall D; Heneghan HM; Miller N; Newell J; Kerin MJ; Dwyer RM
    PLoS One; 2012; 7(11):e50459. PubMed ID: 23226290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increase in mammography detected breast cancer over time at a community based regional cancer center: a longitudinal cohort study 1990-2005.
    Malmgren JA; Atwood MK; Kaplan HG
    BMC Cancer; 2008 May; 8():131. PubMed ID: 18471303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of under-treatment of breast cancer in women 80 years of age and older.
    Van Leeuwen BL; Rosenkranz KM; Feng LL; Bedrosian I; Hartmann K; Hunt KK; Kuerer HM; Ross M; Singletary SE; Babiera GV;
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):315-20. PubMed ID: 20655242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease-specific survival in patient-detected breast cancer.
    Kaplan HG; Malmgren JA
    Clin Breast Cancer; 2006 Jun; 7(2):133-40. PubMed ID: 16800972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between method of detection of breast cancer and stage of disease, method of treatment, and survival in women aged 40 to 49 years.
    Maibenco D; Daoud Y; Phillips E; Saxe A
    Am Surg; 1999 Nov; 65(11):1061-6. PubMed ID: 10551757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
    Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
    Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.